Dr Harold Leroy Rahming, MD in Dyer, IN - Medicare Hospitalist

Dr Harold Leroy Rahming, MD is a medicare enrolled "Hospitalist" physician in Dyer, Indiana. His current practice location is 24 Joliet St, Dyer, Indiana. You can reach out to his office (for appointments etc.) via phone at (219) 865-2141.

Dr Harold Leroy Rahming is licensed to practice in Indiana (license number 01089308A) and he also participates in the medicare program. He does not accept medicare assignments directly but he may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. His NPI Number is 1104316611.

Contact Information

	Dr Harold Leroy Rahming, MD
	24 Joliet St, Dyer, IN 46311-1705
	(219) 865-2141
	(219) 933-2288

Physician's Profile

Full Name	Dr Harold Leroy Rahming
Gender	Male
Speciality	Hospitalist
Location	24 Joliet St, Dyer, Indiana
Accepts Medicare Assignments	Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.

NPI Data:

NPI Number: 1104316611
Provider Enumeration Date: 05/10/2018
Last Update Date: 02/22/2023

Medicare PECOS Information:

PECOS PAC ID: 4789939455
Enrollment ID: I20210713002272

Medical Identifiers

Medical identifiers for Dr Harold Leroy Rahming such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1104316611	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208M00000X	Hospitalist	01089308A (Indiana)	Primary
207R00000X	Internal Medicine	036155393 (Illinois)	Secondary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Harold Leroy Rahming allows following entities to bill medicare on his behalf.

Entity Name	Pmr Illinois Holding Llc
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1770038671 PECOS PAC ID: 2062804909 Enrollment ID: O20220126001647

News Archive

Lower dose of avosentan drug may provide more favorable results in diabetes patients

The drug avosentan substantially reduces urinary protein loss in people with type 2 diabetes and kidney disease, but the drug causes serious side effects, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology (JASN).

Using regular monitoring is most effective in limiting COVID-19 outbreaks in schools

Current methods of limiting the spread of COVID-19 infection in schools are unsuited for controlling outbreaks, with research indicating that regular monitoring measures may be better suited.

FDA approves ipilimumab for metastatic melanoma treatment

The U.S. Food and Drug Administration announced today its approval of a new treatment for advanced melanoma, the deadliest and most difficult-to-treat form of skin cancer.

Patients with heart failure who see physician after leaving hospital are more likely to survive

Patients with heart failure who see a physician in the first month after leaving hospital are more likely to survive than those who do not see a doctor, reports a new study in CMAJ (Canadian Medical Association Journal). The effect is slightly more pronounced in patients who see their regular physician rather than an unfamiliar physician.

Researchers transform skin cells directly into oligodendrocyte precursor cells

Researchers at the Stanford University School of Medicine have succeeded in transforming skin cells directly into oligodendrocyte precursor cells, the cells that wrap nerve cells in the insulating myelin sheaths that help nerve signals propagate.

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Harold Leroy Rahming is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Harold Leroy Rahming, MD Po Box 781076, Detroit, MI 48278-1076 Ph: (317) 528-4800	Dr Harold Leroy Rahming, MD 24 Joliet St, Dyer, IN 46311-1705 Ph: (219) 865-2141

News Archive

Lower dose of avosentan drug may provide more favorable results in diabetes patients

Using regular monitoring is most effective in limiting COVID-19 outbreaks in schools

Current methods of limiting the spread of COVID-19 infection in schools are unsuited for controlling outbreaks, with research indicating that regular monitoring measures may be better suited.

FDA approves ipilimumab for metastatic melanoma treatment

The U.S. Food and Drug Administration announced today its approval of a new treatment for advanced melanoma, the deadliest and most difficult-to-treat form of skin cancer.

Patients with heart failure who see physician after leaving hospital are more likely to survive

Researchers transform skin cells directly into oligodendrocyte precursor cells

Hospitalist Doctors in Dyer, IN

Jeannie Boram Ur, MD
Hospitalist
Medicare: Accepting Medicare Assignments
Practice Location: 24 Joliet St, Dyer, IN 46311
Phone: 219-865-2141 Fax: 219-933-2288

Dr Harold Leroy Rahming, MD - Medicare Hospitalist in Dyer, IN

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medicare Reassignments

Lower dose of avosentan drug may provide more favorable results in diabetes patients

Using regular monitoring is most effective in limiting COVID-19 outbreaks in schools

FDA approves ipilimumab for metastatic melanoma treatment

Patients with heart failure who see physician after leaving hospital are more likely to survive

Researchers transform skin cells directly into oligodendrocyte precursor cells

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Lower dose of avosentan drug may provide more favorable results in diabetes patients

Using regular monitoring is most effective in limiting COVID-19 outbreaks in schools

FDA approves ipilimumab for metastatic melanoma treatment

Patients with heart failure who see physician after leaving hospital are more likely to survive

Researchers transform skin cells directly into oligodendrocyte precursor cells

Hospitalist Doctors in Dyer, IN